Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

2 years ago 296

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How To Increase Your Social Media Reach with Guest Blogging

Mohamed El-Erian says ‘trifecta’ of dangers will haunt the U...

Alibaba Stock Is on a Tear. Here Are 5 Reasons Investors Are...

Oppenheimer Bullish on These 2 Stocks for 70% Upside (Or Mor...

Trending

Popular

Groove Funnels Marketer’s Cruise is Setting Sail in 2023

Non-IT pros will build the bulk of tech products and service...

Akamai adds new capabilities and tools for developers

Tesla hints at Bitcoin support U-turn as Tanzania contemplat...

UK Regulator FCA: Most Investors are Unaware of Crypto Warni...